ENVB
Price
$1.28
Change
+$0.02 (+1.59%)
Updated
Jul 17, 04:53 PM (EDT)
Capitalization
3.11M
ORMP
Price
$2.10
Change
-$0.01 (-0.47%)
Updated
Jul 17, 04:59 PM (EDT)
Capitalization
86.6M
26 days until earnings call
Interact to see
Advertisement

ENVB vs ORMP

Header iconENVB vs ORMP Comparison
Open Charts ENVB vs ORMPBanner chart's image
Enveric Biosciences
Price$1.28
Change+$0.02 (+1.59%)
Volume$600
Capitalization3.11M
Oramed Pharmaceuticals
Price$2.10
Change-$0.01 (-0.47%)
Volume$476
Capitalization86.6M
ENVB vs ORMP Comparison Chart in %
Loading...
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENVB vs. ORMP commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENVB is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (ENVB: $1.26 vs. ORMP: $2.12)
Brand notoriety: ENVB and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENVB: 49% vs. ORMP: 53%
Market capitalization -- ENVB: $3.16M vs. ORMP: $86.6M
ENVB [@Biotechnology] is valued at $3.16M. ORMP’s [@Biotechnology] market capitalization is $86.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENVB’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • ENVB’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, both ENVB and ORMP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENVB’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 2 bullish TA indicator(s).

  • ENVB’s TA Score: 4 bullish, 4 bearish.
  • ORMP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ENVB is a better buy in the short-term than ORMP.

Price Growth

ENVB (@Biotechnology) experienced а -6.67% price change this week, while ORMP (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.06%. For the same industry, the average monthly price growth was +13.69%, and the average quarterly price growth was +40.92%.

Reported Earning Dates

ENVB is expected to report earnings on May 14, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($86.6M) has a higher market cap than ENVB($3.11M). ORMP YTD gains are higher at: -12.397 vs. ENVB (-76.562). ENVB has higher annual earnings (EBITDA): -9.01M vs. ORMP (-21.53M). ORMP has more cash in the bank: 131M vs. ENVB (4.29M). ENVB has less debt than ORMP: ENVB (0) vs ORMP (301K). ORMP has higher revenues than ENVB: ORMP (2M) vs ENVB (0).
ENVBORMPENVB / ORMP
Capitalization3.11M86.6M4%
EBITDA-9.01M-21.53M42%
Gain YTD-76.562-12.397618%
P/E RatioN/A20.91-
Revenue02M-
Total Cash4.29M131M3%
Total Debt0301K-
FUNDAMENTALS RATINGS
ENVB vs ORMP: Fundamental Ratings
ENVB
ORMP
OUTLOOK RATING
1..100
257
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
6577
P/E GROWTH RATING
1..100
10045
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (15) in the Electronics Or Appliances industry is somewhat better than the same rating for ORMP (56) in the Pharmaceuticals Other industry. This means that ENVB’s stock grew somewhat faster than ORMP’s over the last 12 months.

ENVB's Profit vs Risk Rating (100) in the Electronics Or Appliances industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that ENVB’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as ENVB (99) in the Electronics Or Appliances industry. This means that ORMP’s stock grew similarly to ENVB’s over the last 12 months.

ENVB's Price Growth Rating (65) in the Electronics Or Appliances industry is in the same range as ORMP (77) in the Pharmaceuticals Other industry. This means that ENVB’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for ENVB (100) in the Electronics Or Appliances industry. This means that ORMP’s stock grew somewhat faster than ENVB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENVBORMP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXMSF0.750.05
+6.96%
Cemex S.A.B de C.V.
CTTH0.03N/A
N/A
CTT Pharmaceutical Holdings, Inc.
HTSUF28.94N/A
N/A
Hisamitsu Pharmaceutical Co., Ltd.
ORYZF3.28N/A
N/A
Oryzon Genomics SA
SFES0.72-0.06
-8.19%
Safeguard Scientifics, Inc.

ENVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with PRQR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
+2.44%
PRQR - ENVB
43%
Loosely correlated
-0.42%
ALNY - ENVB
36%
Loosely correlated
+3.76%
ORMP - ENVB
33%
Poorly correlated
+0.96%
SLNCF - ENVB
28%
Poorly correlated
N/A
XBIT - ENVB
27%
Poorly correlated
+8.36%
More